NIMS Centre for Genomic Medicine

What NIMS Centre for Genomic Medicine does

NIMS Centre for Genomic Medicine is a specialized genomics research and diagnostics center established in 2021 under the Noorul Islam Educational Trust in Neyyattinkara, Thiruvananthapuram, Kerala. Operating within the larger NIMS Medicity hospital campus — a 500-bed NABH- and NAAC A-accredited tertiary care teaching institution with 200+ consultants and 1,550+ nursing/paramedical staff — the center delivers a portfolio organized across three pillars: (1) clinical genetics services including genetic consultation and counseling for prospective parents and patients; (2) molecular diagnostics spanning infectious disease, molecular genetics, and molecular pathology; and (3) research and analytical services covering molecular biology/genomics, phytochemistry, cell culture, microbiology, and bioinformatics. Its R&D division pursues seven focus areas: oncogenomics and cancer biomarker discovery, antimicrobial resistance, infectious disease genomics, neuroimmunology, molecular genetics of hereditary disorders, reproductive genomics, and nanobiotechnology.

The center monetizes through fee-for-service diagnostic testing, professional genetic counseling fees, structured training programs (certificates, internships, workshops), and contract research services for institutional clients. Customer segments are diversified across general patient populations in South Kerala and South Tamil Nadu, insured patients via a 14+ TPA and 16+ insurer network, government scheme beneficiaries (CMCHIS, PMRF), economically disadvantaged patients served under free-care programs, corporate executives purchasing preventive genetic screening packages, and international medical tourists. Distribution leverages on-campus facilities plus micro hospitals, nano clinics, and rural telemedicine units. The center holds multiple accreditations including BIRAC-approved research centre status, KASE Centre of Excellence designation, and Drug Controller General of India-approved ethics committee, positioning it for government tenders and academic research funding.

Name

NIMS Centre for Genomic Medicine

Legal name

NIMS Centre for Genomic Medicine

Website

https://nimshospital.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

NIMS Centre for Genomic Medicine is a 2021-established genomics research and diagnostics center in Thiruvananthapuram, Kerala, operating under Noorul Islam Educational Trust. It delivers genetic counseling, molecular diagnostics, and biotech research services to patients, institutions, and trainees across South Kerala.

Ownership category

akta.pro rank

Product category

Genomic Diagnostics and Molecular Pathology Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

akta.pro secondary industries

Genomic Profiling & Sequencing-Based Precision Medicine (HLAAANAA), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Neurogenetics & Rare Neurologic Diseases (HLAKAIAO)

Keywords

• Molecular diagnostics services
• Genetic testing services
• Genomics research services
• Molecular pathology diagnostics
• Bioinformatics analytical services

Headquarters

HQ city

Trivandrum, Kerala

HQ country

India

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Healthcare Services: Tertiary care super-specialty hospital providing diagnostic, treatment, and surgical services across 40+ departments including cardiology, nephrology, oncology, orthopedics, and more
2. Genomic Diagnostics Services: Molecular diagnostics including genetic testing, molecular infectious disease testing, molecular genetics, and molecular pathology services for patients and referring healthcare providers
3. Genetic Counseling: Genetic counseling and testing services for prospective parents ensuring informed reproductive decisions
4. Training and Education Programs: Internships, academic projects, workshops, certificate courses, and faculty development programs
5. Research and Analytical Services: Molecular biology/genomics, phytochemistry, cell culture, microbiology, and bioinformatics services for research institutions and industries
6. Insurance and Corporate Partnerships: Cashless treatment services through partnerships with multiple TPAs, insurers, and government health schemes

Pricing tiers

Go-to-market motion1 record

Distribution channels7 records

Marketing channels8 records

Core offering

NIMS Centre for Genomic Medicine delivers molecular diagnostics, genetic counseling, and genomics-focused research services from its facility within the NIMS Medicity hospital campus in Thiruvananthapuram, Kerala. Its portfolio covers genetic consultation for prospective parents, molecular infectious disease, molecular genetics and molecular pathology diagnostics, and research and analytical services spanning molecular biology, phytochemistry, cell culture, microbiology, and bioinformatics. It also operates paid training programs including internships, workshops, certificate courses, and faculty development initiatives across genomics and biotechnology disciplines.

Product overview

NIMS Centre for Genomic Medicine is a specialized genomics research and diagnostics center operating within the NIMS Medicity hospital campus in Thiruvananthapuram, Kerala. The center offers a portfolio of services organized into three core pillars: (1) Genetic Consultation, providing genetic counselling and testing for prospective parents and patients; (2) Diagnostics, encompassing Molecular Infectious Disease, Molecular Genetics, and Molecular Pathology testing services; and (3) Research & Analytical Services covering Molecular Biology/Genomics, Phytochemistry, Cell Culture, Microbiology, and Bioinformatics. Its R&D division pursues focused research in Oncogenomics and Cancer Biomarker Discovery, Antimicrobial Resistance, Infectious Disease Genomics, Neuroimmunology, Molecular Genetics, Reproductive Genomics, and Nanobiotechnology. The center also delivers Training Programs including internships, academic projects, workshops, certificate courses, and faculty development initiatives.

Differentiator

Problem solved

Functional benefit

Products and services

• Genetic Consultation Genetic counseling and testing services provided to prospective parents and patients, exploring genetic factors influencing fertility, pregnancy outcomes, and hereditary conditions to enable informed reproductive decisions and healthier pregnancies.
• Molecular Infectious Disease Diagnostics Molecular diagnostic services focused on identifying and characterizing infectious disease pathogens using genomic technologies to confirm causes of communicable and non-communicable diseases for treating physicians and patients.
• Molecular Genetics Diagnostics Molecular genetics diagnostic services investigating the genetic basis of hereditary diseases and rare genetic disorders to improve diagnosis and identify therapeutic targets for patients and clinicians.
• Molecular Pathology Diagnostics Molecular pathology diagnostic services applying core molecular biology techniques to confirm disease causes and support clinical decision-making for treating physicians.
• Research and Analytical Services Research and analytical services spanning molecular biology and genomics, phytochemistry, cell culture, microbiology, and bioinformatics, delivered to research institutions and industries to advance scientific knowledge and drive innovation.
• Training Programs in Genomics and Biotechnology Academic and professional training offerings including internships, academic project guidance, workshops, certificate courses, and faculty development programs across genomics and biotechnology disciplines for students and faculty.

Quantifiable outcome

• 376 free heart surgeries performed for underprivileged patients
• +4 more outcomes

Named customers8 records

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature11 records

Partnerships

14 partnerships are on record, tiered core and minor.

• Sri Sathya Sai Orphanage Trust – KeralacoreStrategic or Co-development Partner · 1 January 2021MoU signed to perform minimum 12 renal transplants per year for underprivileged patients living below poverty line. This partnership extends NIMS's commitment to providing affordable renal transplantation services.
• Mammootty Fans AssociationcoreGTM or Marketing PartnerAssociation with Mammootty Fans Association for carrying out free heart surgeries for those below poverty line under Heart to Heart Project. Padma Shri Bharat Mammootty serves as Project Ambassador.
• Asia Rescue & Medical Services Pvt. LtdcoreChannel Partner/ Reseller/ DistributorThird Party Administrator (TPA) for cashless insurance claims processing
• Medi Assist India TPA services Pvt. Ltd.coreChannel Partner/ Reseller/ DistributorThird Party Administrator (TPA) for cashless insurance claims processing
• Md India Healthcare TPA Services Pvt. Ltd.coreChannel Partner/ Reseller/ DistributorThird Party Administrator (TPA) for cashless insurance claims processing
• Medicare TPAcoreChannel Partner/ Reseller/ DistributorThird Party Administrator (TPA) for cashless insurance claims processing
• National InsurancecoreChannel Partner/ Reseller/ DistributorGovernment insurance provider for cashless treatment under government health schemes
• Oriental InsurancecoreChannel Partner/ Reseller/ DistributorGovernment insurance provider for cashless treatment under government health schemes
• United India InsurancecoreChannel Partner/ Reseller/ DistributorGovernment insurance provider for cashless treatment under government health schemes
• New India AssurancecoreChannel Partner/ Reseller/ DistributorGovernment insurance provider for cashless treatment under government health schemes
• Life Insurance CorporationcoreChannel Partner/ Reseller/ DistributorGovernment insurance provider for cashless treatment under government health schemes
• Chief Minister's Comprehensive Health Insurance Scheme (Tamil Nadu)coreOthersEmpanelled under the Chief Minister's comprehensive health insurance scheme (Government of Tamil Nadu)
• Prime Minister's Relief FundcoreOthersEmpanelled under the Prime Minister's relief fund for providing healthcare to beneficiaries
• Triveni ConsumerfedminorStrategic or Co-development PartnerAssociation during COVID pandemic for NIMS Free Food Items Kit project for inpatients - providing grocery coupons at discharge

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• MedGenome: India-headquartered clinical genomics and molecular diagnostics company offering genetic testing, hereditary disease panels, oncology, reproductive genomics and infectious disease testing — directly comparable service portfolio to NIMS Centre for Genomic Medicine.
• MapMyGenome: Indian preventive and personal genomics company offering genetic testing, counselling, and molecular diagnostics — directly comparable in clinical genomics and patient-facing genetic counselling to NIMS Centre for Genomic Medicine.
• Strand Life Sciences: India-based clinical genomics and bioinformatics diagnostics provider offering hereditary cancer, prenatal, rare disease and pharmacogenomic testing, with significant overlap to NIMS's genetic counselling and molecular diagnostics services.

Broad incumbents

• Apollo Diagnostics: Large Indian diagnostic network offering routine and specialised testing including molecular diagnostics — competes for the same patient pool but with a national footprint and far larger test catalogue than NIMS.
• Dr. Lal PathLabs: Pan-India diagnostic chain offering a wide range of molecular and infectious disease testing — competes for clinical diagnostics referrals but with national reach and broader test menu than NIMS Centre for Genomic Medicine.
• Eurofins Genomics India: Global genomics services provider with Indian presence offering sequencing, genotyping and molecular biology services — directly comparable on research/analytical genomics services to NIMS's offerings.
• Thyrocare Technologies: Pan-India diagnostic chain offering a broad preventive and molecular diagnostics menu including select genetic tests at scale — competes broadly for molecular diagnostic referrals but with much wider geographic reach than NIMS.

Emerging players

• 4baseCare: India-focused oncology genomics startup offering molecular profiling and precision oncology solutions for cancer patients — overlaps with NIMS's oncogenomics and cancer biomarker research focus area.
• Syngene International: India-based CRO offering genomics, molecular biology, bioinformatics, and cell culture research services — comparable on the contract research and analytical services side of NIMS's offering.

Others

• Agilent Technologies India: Global life sciences and molecular diagnostics tools and services company enabling genomics workflows — adjacent peer providing instruments, reagents and bioinformatics that support molecular diagnostic labs like NIMS.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/nimscgm
• YouTubeyoutube.com/channel/UCYDYbaBK8Z4o8EWDTuEy-RQ
• Facebookfacebook.com/nimscgm
• LinkedInlinkedin.com/company/nimscgm
• Instagraminstagram.com/nimscgm

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NIMS Centre for Genomic Medicine